Akebia Ther (AKBA)
$1.92 -$0.07 (-3.54%) 4:38 PM 12/11/24
NASDAQ | $USD | Drug Manufacturers - Specialty & GenericStock Data
-
Market Cap
$447.27M -
Day's Range
$1.86 - $1.96 -
Volume
2,193,329 -
52 Week Low / High
$0.80 - $2.48 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
AKBA's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $3.88
- Target Price
Company News
-
Akebia Secures $55 Million Term Loan Financing — Jan 30th, 2024
Strengthens Balance Sheet Ahead of Potential Vadadustat Approval on March 27, 2024 CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today annou...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$